Priority Date: 06.02.12 (FR 20120051089)

USE OF miR-199a-5p, TARGETS AND/OR INHIBITORS THEREOF FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF FIBROPROLIFERATIVE DISORDERS

  • Application ID: EP13712915
  • Status: The patent has been granted

Attorneys

Employment test 201 - 500 employees
Company dna novagraaf
operating since 1888
1095.45
Headquarter in Amsterdam and 16 offices
active in Legal Services and IP Consulting
Company dna novagraaf technologies
no operation time available
5 offices
active in Legal Services

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.02.2012 - Priority Date (FR 20120051089)
  • 15.08.2013 - Publication A1 (WO2013118066)
  • 17.12.2014 - Publication A1 (EP2812449)
  • 12.07.2017 - Publication B1 (EP2812449)

IPC Classification